Fisher M. Diabetes Drug Notes 2022

Textbook in PDF format

Diabetes is becoming more common in both older and younger generations and in keeping with this escalation in cases, there are an ever increasing number of drugs and drug classes that are suitable to treat hyperglycaemia. In a unique blend of diabetes practice, clinical pharmacology, and cardiovascular medicine, Diabetes Drug Notes describes the principles of clinical pharmacology with regards to diabetes prescribing. Each drug class for the treatment of diabetes is covered in detail, along with the effect on the cardiovascular and renal systems caused by each drug. Building upon the success of their “Drug Notes” series for Practical Diabetes and their “Drugs for Diabetes” series in the British Journal of Cardiology, the team of experts focuses on the glycaemic management of type 1 and type 2 diabetes, with other effects of antidiabetic drugs covered as well.
Introduction
Clinical Pharmacology of Antidiabetic Drugs
Metformin
Sulfonylureas and Meglitinides
DPP-4 Inhibitors
SGLT2 Inhibitors
GLP-1 Receptor Agonists
Animal and Human Insulins
Short-acting Insulin Analogues
Long-acting Insulin Analogues
Devices
Acarbose and Alpha Glucosidase Inhibitors
Glitazones and Glitazars
Other Antidiabetic Drugs
Future Antidiabetic Drugs
Guidelines on Antidiabetic Drugs
Prescribing Antidiabetic Drugs